New study tests wearable patch to catch hidden heart rhythm problems

NCT ID NCT07671677

Not yet recruiting Knowledge-focused Sponsor: Heart Rhythm Clinical and Research Solutions, LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will enroll 100 people who have already had a heart procedure (pulsed field ablation) for atrial fibrillation. Participants will wear a BodyGuardian monitor for a period after the procedure to see if it catches any return of irregular heartbeats. The study also asks patients and their doctors about their experience with the monitor. The goal is to learn how well this wearable works in real-world settings and how often insurance covers it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that the BodyGuardian monitor is a practical tool for tracking AF recurrence after ablation, potentially improving follow-up care.
What could go wrong: This is an observational study, not a treatment trial. It is small (100 participants) and only collects data, so it cannot prove the monitor improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF)

Contacts and locations

Locations

Allegheny General Hospital

Pittsburgh, Pennsylvania, 15212, United States
Arrhythmia Center of South Florida

Delray Beach, Florida, 33484, United States
St. Mark's Hospital

Salt Lake City, Utah, 84124, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.